Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price Deficiency

January 3, 2024

https://www.globenewswire.com/news-release/2024/01/03/2803627/0/en/Homology-Medicines-Receives-NASDAQ-Notification-Regarding-Minimum-Bid-Price-Deficiency.html

Homology Medicines has an initial 180-day period through June 26, 2024 to regain compliance with Minimum Bid Price Requirement

BEDFORD, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) — Homology Medicines, Inc. (Nasdaq:FIXX) today announced that it received notification (“Nasdaq Notification”) from The Nasdaq Stock Market LLC (“Nasdaq”) on December 29, 2023 indicating that, for the last thirty (30) consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on the Nasdaq Global Select Market (Nasdaq Listing Rule 5450(a)(1)).

Read more at globenewswire.com

Related news for (FIXX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.